An HTS FP assay able to selectively identify STAT3-DBD inhibitors
An HTS FP assay able to selectively identify STAT3-DBD inhibitors |
https://doi.org/10.18632/oncotarget.26155
Fiorella Meneghetti,
and Daniela Barlocco
|
34451-34452 |
Can drug repurposing stop “chase and run” between aldehydes and reactive sulfur species in anti-cancer therapy?
Can drug repurposing stop “chase and run” between aldehydes and reactive sulfur species in anti-cancer therapy? |
https://doi.org/10.18632/oncotarget.26170
Makoto Suematsu
|
34453-34454 |
Unfolding the roles of resveratrol in p53 regulation
Unfolding the roles of resveratrol in p53 regulation |
https://doi.org/10.18632/oncotarget.26185
Rafaela Muniz de Queiroz,
and Carol Prives
|
34455-34456 |
A new B-Raf inhibitor combo for advanced melanoma
A new B-Raf inhibitor combo for advanced melanoma |
https://doi.org/10.18632/oncotarget.26171
Marjam-Jeanette Barysch,
Joanna Mangana,
and Reinhard Dummer
|
34457-34458 |
Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1
Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 |
https://doi.org/10.18632/oncotarget.26108
Robbie L. McLeod,
Minilik H. Angagaw,
Toya Nath Baral,
Liming Liu,
Raymond Joseph Moniz,
Jason Laskey,
SuChun Hsieh,
Mike Lee,
Jin-Hwan Han,
Hassan Issafras,
Sarah Javaid,
Andrey Loboda,
Svetlana Sadekova,
Joann A. O'Connor,
Archie Tse,
and Juha Punnonen
|
34459-34470 |
The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells
The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells |
https://doi.org/10.18632/oncotarget.26121
Chantal Bou-Hanna,
Anne Jarry,
Jean-François Mosnier,
Céline Bossard,
and Christian L. Laboisse
|
34471-34484 |
Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study
Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study |
https://doi.org/10.18632/oncotarget.26128
Céline Lavalette,
Brigitte Trétarre,
Xavier Rebillard,
Pierre-Jean Lamy,
Sylvie Cénée,
and Florence Menegaux
|
34485-34494 |
Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation
Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation |
https://doi.org/10.18632/oncotarget.26130
Gautam Adhikary,
Daniel Grun,
H. Richard Alexander,
Joseph S. Friedberg,
Wen Xu,
Jeffrey W. Keillor,
Sivaveera Kandasamy,
and Richard L. Eckert
|
34495-34505 |
Characteristic analysis of TCR β-chain CDR3 repertoire for pre-and post-liver transplantation
Characteristic analysis of TCR β-chain CDR3 repertoire for pre-and post-liver transplantation |
https://doi.org/10.18632/oncotarget.26138
Guiqi Yang,
Minglin Ou,
Huaizhou Chen,
Changchun Guo,
Jiejing Chen,
Hua Lin,
Donge Tang,
Wen Xue,
Wenlong Li,
Weiguo Sui,
and Yong Dai
|
34506-34519 |
Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study
Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study |
https://doi.org/10.18632/oncotarget.26145
Takatsugu Ogata,
Hironaga Satake,
Misato Ogata,
Yukimasa Hatachi,
Kentaro Inoue,
Madoka Hamada,
and Hisateru Yasui
|
34520-34527 |
3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations
3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations |
https://doi.org/10.18632/oncotarget.26160
Alexander L. Kovalchuk,
Tomomi Sakai,
Chen-Feng Qi,
Wendy Du Bois,
Wesley A. Dunnick,
Michel Cogné,
and Herbert C. Morse III
|
34528-34542 |
Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and prolongs virus persistence at tumor site
Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and prolongs virus persistence at tumor site |
https://doi.org/10.18632/oncotarget.26167
Xinping Fu,
Lihua Tao,
and Xiaoliu Zhang
|
34543-34553 |
Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling
Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling |
https://doi.org/10.18632/oncotarget.26177
Eisuke Horigome,
Michiru Fujieda,
Tadashi Handa,
Ayaka Katayama,
Masashi Ito,
Ami Ichihara,
Daiki Tanaka,
Navchaa Gombodorj,
Shinji Yoshiyama,
Arito Yamane,
Keiichi Yamada,
Jun Horiguchi,
Kazuo Shinozuka,
Tetsunari Oyama,
Masahiko Nishiyama,
and Susumu Rokudai
|
34554-34566 |
XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies
XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies |
https://doi.org/10.18632/oncotarget.26179
Han Bit Baek,
Alan P. Lombard,
Stephen J. Libertini,
Aleida Fernandez-Rubio,
Ruth Vinall,
Regina Gandour-Edwards,
Rachel Nakagawa,
Kathleen Vidallo,
Kristine Nishida,
Salma Siddiqui,
Hiromi Wettersten,
Yosef Landesman,
Robert H. Weiss,
Paramita M. Ghosh,
and Maria Mudryj
|
34567-34581 |
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma |
https://doi.org/10.18632/oncotarget.26180
Utkarsh Painuly,
Vijay Ramakrishnan,
Teresa Kimlinger,
Linda Wellik,
Jessica Haug,
Wilson Gonsalves,
Lintao Bi,
Zhongxia Huang,
S. Vincent Rajkumar,
and Shaji Kumar
|
34582-34594 |
Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells
Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells |
https://doi.org/10.18632/oncotarget.26191
Margit Schwartz,
Sabine Böckmann,
and Burkhard Hinz
|
34595-34616 |
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Surrogate endpoints in advanced sarcoma trials: a meta-analysis |
https://doi.org/10.18632/oncotarget.26166
Marion Savina,
Saskia Litière,
Antoine Italiano,
Tomasz Burzykowski,
Franck Bonnetain,
Sophie Gourgou,
Virginie Rondeau,
Jean-Yves Blay,
Sophie Cousin,
Florence Duffaud,
Hans Gelderblom,
Alessandro Gronchi,
Ian Judson,
Axel Le Cesne,
Paul Lorigan,
Joan Maurel,
Winette van der Graaf,
Jaap Verweij,
Simone Mathoulin-Pélissier,
and Carine Bellera
|
34617-34627 |
The clinical relevance of progestogens in hormonal contraception: Present status and future developments
The clinical relevance of progestogens in hormonal contraception: Present status and future developments |
https://doi.org/10.18632/oncotarget.26015
Pedro-Antonio Regidor
|
34628-34638 |
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
https://doi.org/10.18632/oncotarget.26213
Marina Cazzaniga,
Claudio Verusio,
Mariangela Ciccarese,
Alberto Fumagalli,
Donata Sartori,
Maria Rosaria Valerio,
Mario Airoldi,
Gabriella Moretti,
Corrado Ficorella,
Valentina Arcangeli,
Lucrezia Diodati,
Alberto Zambelli,
Antonio Febbraro,
Daniele Generali,
Mirco Pistelli,
Ornella Garrone,
Antonino Musolino,
Patrizia Vici,
Michela Maur,
Lucia Mentuccia,
Nicla La Verde,
Giulia Bianchi,
Salvatore Artale,
Livio Blasi,
Matilde Piezzo,
Francesco Atzori,
Anna Turletti,
Chiara Benedetto,
Maria Concetta Cursano,
Alessandra Fabi,
Vittorio Gebbia,
Alessio Schirone,
Raffaella Palumbo,
Antonella Ferzi,
Antonio Frassoldati,
Claudio Scavelli,
Luca Clivio,
and Valter Torri on behalf of The EVA Study Group
|
34639-34640 |
Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET
Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET |
https://doi.org/10.18632/oncotarget.26214
Ido D. Weiss,
Lyn M. Huff,
Moses O. Evbuomwan,
Xin Xu,
Hong Duc Dang,
Daniel S. Velez,
Satya P. Singh,
Hongwei H. Zhang,
Paul J. Gardina,
Jae-Ho Lee,
Liza Lindenberg,
Timothy G. Myers,
Chang H. Paik,
David S. Schrump,
Stefania Pittaluga,
Peter L. Choyke,
Tito Fojo,
and Joshua M. Farber
|
34641-34641 |